ASEAN Capacity for Vaccine Research and Development and Production
COVID-19 has had a devastating effect on the ASEAN region, which has recorded over 27 million cases of the virus. Access to COVID-19 vaccination has significantly reduced the spread of the disease and limited the number of severe COVID-19 cases, but it has also impacted routine immunization coverage. Countless strategies have been developed to ensure vaccine equity, which were swiftly translated from political assessment to practical action; however, they failed to address the sustained growth of the COVID-19 pandemic and the emergence of variants of concerns, requiring ongoing vaccine booster doses. The pandemic revealed weaknesses in ASEAN's regional vaccine capacity, including in research and development, manufacturing infrastructure and human resources, which made the region particularly vulnerable during COVID-19 surges, as it was highly dependent on vaccine imports. Despite the existence of an established framework for ASEAN collaboration on vaccines, there has been minimal coordination between member states to collectively procure COVID-19 vaccines. Initial consultations with various stakeholders involved in vaccination and equitable access in the ASEAN region highlighted several gaps related to ensuring a sustained supply of quality vaccines throughout the life cycle, as well as several critical areas that require immediate attention. The political commitment to address these issues has been shaped by the evolving pandemic scenarios. The ASEAN Vaccine Security and Self-Reliance (AVSSR) initiative was launched just before the COVID-19 pandemic began and was agreed upon and endorsed by the region's ten leaders during the 34th ASEAN Summit in November 2019. Future regional strategies, policies and plans must ensure consistency with this important ASEAN initiative.
| Main Author: | |
|---|---|
| Format: | Report biblioteca |
| Language: | English en_US |
| Published: |
Washington, DC: World Bank
2023-06-16
|
| Subjects: | COVID-19, VACCINE, ASEAN REGION, |
| Online Access: | http://documents.worldbank.org/curated/en/099061623000041573/P17809207abd440ae0be820aced53cba398 https://openknowledge.worldbank.org/handle/10986/40377 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | COVID-19 has had a devastating effect
on the ASEAN region, which has recorded over 27 million
cases of the virus. Access to COVID-19 vaccination has
significantly reduced the spread of the disease and limited
the number of severe COVID-19 cases, but it has also
impacted routine immunization coverage. Countless strategies
have been developed to ensure vaccine equity, which were
swiftly translated from political assessment to practical
action; however, they failed to address the sustained growth
of the COVID-19 pandemic and the emergence of variants of
concerns, requiring ongoing vaccine booster doses. The
pandemic revealed weaknesses in ASEAN's regional
vaccine capacity, including in research and development,
manufacturing infrastructure and human resources, which made
the region particularly vulnerable during COVID-19 surges,
as it was highly dependent on vaccine imports. Despite the
existence of an established framework for ASEAN
collaboration on vaccines, there has been minimal
coordination between member states to collectively procure
COVID-19 vaccines. Initial consultations with various
stakeholders involved in vaccination and equitable access in
the ASEAN region highlighted several gaps related to
ensuring a sustained supply of quality vaccines throughout
the life cycle, as well as several critical areas that
require immediate attention. The political commitment to
address these issues has been shaped by the evolving
pandemic scenarios. The ASEAN Vaccine Security and
Self-Reliance (AVSSR) initiative was launched just before
the COVID-19 pandemic began and was agreed upon and endorsed
by the region's ten leaders during the 34th ASEAN
Summit in November 2019. Future regional strategies,
policies and plans must ensure consistency with this
important ASEAN initiative. |
|---|